Format

Send to

Choose Destination
See comment in PubMed Commons below
Rheum Dis Clin North Am. 2004 May;30(2):329-47, vii.

Infliximab treatment of rheumatoid arthritis.

Author information

  • 1Department of Rheumatology, Imperial College, London, UK. r.maini@imperial.ac.uk

Abstract

Infliximab was the first anti-TNF agent used to treat rheumatoid arthritis to provide proof of concept of the role of TNF-alpha in this condition. It has become widely used since, principally as an effective treatment in combination with methotrexate, but also as monotherapy for the treatment of Crohn's disease, ankylosing spondylitis,and psoriatic arthritis. The benefits of infliximab in controlling signs and symptoms, improving quality of life, preventing structural joint damage, and possible healing of bone provide an important option for the treatment of rheumatoid arthritis.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk